Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 63

1.

New biologics for glomerular disease on the horizon.

Karras A, Jayne D.

Nephron Clin Pract. 2014;128(3-4):283-91. doi: 10.1159/000368593. Epub 2014 Nov 7. Review.

2.

New biologics in the treatment of rare glomerular diseases of childhood.

Cravedi P, Angeletti A, Remuzzi G.

Curr Opin Pharmacol. 2017 Apr;33:27-33. doi: 10.1016/j.coph.2017.03.010. Epub 2017 Apr 26. Review.

PMID:
28456094
3.

Biologics for the treatment of autoimmune renal diseases.

Holdsworth SR, Gan PY, Kitching AR.

Nat Rev Nephrol. 2016 Apr;12(4):217-31. doi: 10.1038/nrneph.2016.18. Epub 2016 Mar 7. Review.

PMID:
26949177
4.

Biologic agents in the treatment of glomerulonephritides.

Yeo SC, Liew A.

Nephrology (Carlton). 2015 Nov;20(11):767-87. doi: 10.1111/nep.12530. Review.

PMID:
26040770
5.

[Use of biologicals in psoriasis].

Friedrich M, Philipp S, Sabat R, Asadullah K, Sterry W.

Z Rheumatol. 2003 Oct;62(5):439-49. Review. German.

PMID:
14579031
6.

Lupus nephritis: from pathogenesis to targets for biologic treatment.

Liu Y, Anders HJ.

Nephron Clin Pract. 2014;128(3-4):224-31. doi: 10.1159/000368581. Epub 2014 Nov 8. Review.

7.

Biologics in SLE: the current status.

Rajadhyaksha AG, Mehra S, Nadkar MY.

J Assoc Physicians India. 2013 Apr;61(4):262-7.

PMID:
24482965
8.

Novel B cell therapeutic targets in transplantation and immune-mediated glomerular diseases.

Vincenti F, Cohen SD, Appel G.

Clin J Am Soc Nephrol. 2010 Jan;5(1):142-51. doi: 10.2215/CJN.04580709. Epub 2009 Dec 10. Review.

9.

Proteinuria: detection and role in native renal disease progression.

Gorriz JL, Martinez-Castelao A.

Transplant Rev (Orlando). 2012 Jan;26(1):3-13. doi: 10.1016/j.trre.2011.10.002. Review.

PMID:
22137726
10.

The lymphocyte migration inhibitor FTY720 attenuates experimental hypertensive nephropathy.

Krämer S, Binder E, Loof T, Wang-Rosenke Y, Martini S, Khadzhynov D, Budde K, Neumayer HH, Peters H.

Am J Physiol Renal Physiol. 2009 Jul;297(1):F218-27. doi: 10.1152/ajprenal.90617.2008. Epub 2009 May 13.

11.

[Rationale and clinical evidence for the use of rituximab in glomerular diseases].

Mani LY, Vogt B, Burnier M, Golshayan D.

Rev Med Suisse. 2011 Apr 13;7(290):819-24. Review. French.

PMID:
21595313
12.

[Proteins in rheumatology and clinical immunology].

Villiger PM.

Ther Umsch. 2011 Nov;68(11):603-9. doi: 10.1024/0040-5930/a000220. Review. German.

PMID:
22045522
13.

[Slowing the progression of chronic renal insufficiency with captopril in rats with spontaneous arterial hypertension and adriamycin nephropathy].

Jovanović DB, Jovović Dj, Varagić J, Dimitrijević J, Dragojlović Z, Djukanović L.

Srp Arh Celok Lek. 2002 Mar-Apr;130(3-4):73-80. Serbian.

14.

Treatment of HIV-associated nephropathies.

Elewa U, Sandri AM, Rizza SA, Fervenza FC.

Nephron Clin Pract. 2011;118(4):c346-54; discussion c354. doi: 10.1159/000323666. Epub 2011 Feb 3. Review.

15.

Current treatment of psoriasis with biologics.

Kunz M.

Curr Drug Discov Technol. 2009 Dec;6(4):231-40. Review.

PMID:
20025590
16.

Monoclonal antibody treatments for rheumatoid arthritis.

Bossaller L, Rothe A.

Expert Opin Biol Ther. 2013 Sep;13(9):1257-72. doi: 10.1517/14712598.2013.811230. Epub 2013 Jun 21. Review.

PMID:
23789825
17.

Targeting signaling pathways in glomerular diseases.

Henique C, Tharaux PL.

Curr Opin Nephrol Hypertens. 2012 Jul;21(4):417-27. doi: 10.1097/MNH.0b013e328354a598. Review.

PMID:
22660552
18.

Novel therapeutic agents for systemic lupus erythematosus.

Gescuk BD, Davis JC Jr.

Curr Opin Rheumatol. 2002 Sep;14(5):515-21. Review.

PMID:
12192247
19.

Systemic lupus erythematosus and other autoimmune rheumatic diseases: challenges to treatment.

Murphy G, Lisnevskaia L, Isenberg D.

Lancet. 2013 Aug 31;382(9894):809-18. doi: 10.1016/S0140-6736(13)60889-2. Epub 2013 Aug 23. Review.

PMID:
23972423
20.

Kidney diseases caused by complement dysregulation: acquired, inherited, and still more to come.

Heeringa SF, Cohen CD.

Clin Dev Immunol. 2012;2012:695131. doi: 10.1155/2012/695131. Epub 2012 Nov 14. Review.

Supplemental Content

Support Center